Kelly Financial Services LLC Edwards Lifesciences Corp Transaction History

Kelly Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 17, 2024	BUY	$72.54 - $95.56 $9,067 - $11,945	125 Added 1041.67%	137 $13,000
Q1 2023 Jul 17, 2024	SELL	$74.26 - $84.51 $891 - $1,014	-12 Reduced 50.0%	12 $993,000
Q4 2021 Jul 17, 2024	SELL	$106.37 - $130.68 $2,446 - $3,005	-23 Reduced 48.94%	24 $3.11 Million
Q3 2021 Jul 17, 2024	SELL	$102.91 - $122.75 $496,129 - $591,777	-4,821 Reduced 99.03%	47 $5.32 Million
Q2 2021 Jul 17, 2024	BUY	$83.84 - $104.76 $404,192 - $505,047	4,821 Added 10257.45%	4,868 $47,000
Q1 2021 Jul 17, 2024	BUY	$78.68 - $90.67 $1,101 - $1,269	14 Added 42.42%	47 $3.93 Million
Q2 2020 Jul 17, 2024	BUY	$57.54 - $76.95 $1,265 - $1,692	22 Added 200.0%	33 $2.28 Million
Q1 2020 Jul 17, 2024	BUY	$52.41 - $81.0 $576 - $891	11 New	11 $2.08 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.